Navigation Links
Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach
Date:4/7/2008

Delivery Systems and Specific Molecular Structures Needed for siRNA

Therapeutic Success

LONDON, April 7, 2008 /PRNewswire/ -- Silence Therapeutics plc (AIM:SLN) Europe's leading RNAi-focused biotechnology company, today comments on two recent journal articles: Nature(1) "Sequence-and target-independent angiogenesis suppression by siRNA via TLR3" Mark E. Kleinman, et. al., and Molecules and Cells(2) "Immune Activation by siRNA/Liposome Complexes in Mice is Sequence-Independent: Lack of a Role for Toll-like Receptor 3," Kim et. al. In these two publications, researchers questioned current thinking on the mode of action of siRNA therapeutics suggesting that they work by mechanisms other than via specific gene silencing.

Data published in the Nature article (Kleinman et. al.) have been interpreted in recent days in the lay press as a "Setback for Some RNA-Based Drugs" (New York Times(5)). Silence Therapeutics views the cited Nature paper, and another recent paper in Molecules and Cells(2) as highlighting the need for a functional delivery system to ensure the therapeutic siRNA is able to enter cells and achieve gene silencing.

Both studies further reinforce the importance of chemically modifying siRNA to create molecular structures which do not cause unwanted immune stimulation such as cytokine release and interferon response.

The two new studies support the long-standing development approach of Silence Therapeutics, which has focused its research on developing both a potent RNAi-mediating delivery system (AtuPLEX) and chemically-modified siRNA (AtuRNAi) molecules.

Jeff Vick, CEO of Silence Therapeutics, said, "More than eight years ago, Silence Therapeutics recognized the need for, and pioneered the development of, a functional systemic RNAi delivery system that combines proprietary chemical modification and lipid technologies to achieve efficient intracellular uptake without triggering an immune s
'/>"/>

SOURCE Silence Therapeutics plc
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
2. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
3. Studies Attribute Recent Increase in Multiple Myeloma Survival to Novel Therapies
4. Recent Findings from the Framingham Offspring Study Show Low Numbers of LDL Particles (LDL-P) by NMR are Associated With Fewer Heart Disease Related Events than Equivalently Low Levels of LDL Cholesterol (LDL-C).(1)
5. Recent Studies Suggest Popular Diet Pill Relacore Reduces Acne Breakouts
6. Alegent Health Sees Positive Results From Recent Clinician Usability Study Collaboration With Siemens and Motion Computing
7. Recent Data Study Suggests Cortisol Could Help Alleviate Suffering for Those With Chronic Fatigue Syndrome and Fibromyalgia
8. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
9. Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
10. Intradigm Study Shows Ability of siRNAs Systemically Delivered With TargeTran(TM) System to Suppress Tumor-Induced Angiogenesis in Mice
11. Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...TER,N.J.,Nov.25/PRNewswire/--TheFDAgrantedtraditio...non-nucleosidereversetranscriptaseinhibitor(NNRTI)...eintreatment-experiencedadultswhoareexperiencingvi...dotherantiretroviral(ARV)agents.Thetraditionalappr...sDUET-1andDUET-2.INTELENCEiscurrentlymarketedinthe...
(Date:11/25/2009)...IDGE,N.J.,Nov.25/PRNewswire/--RegadoBiosciences,ap...mboticaptamerswithactivecontrolagents,announcedtha...thePiperJaffray21stAnnualHealthCareConferenceatthe...tionwillbegivenat1:10pm(EST)onTuesday,December1and...hasisontheleaddevelopmentprogram,theanticoagulants...
(Date:11/25/2009)...Y,Calif.,Nov.25/PRNewswire-FirstCall/--Abaxis,Inc....ngpoint-of-carebloodanalysissystems,announcedtoday...,willpresentatthe21stAnnualPiperJaffrayHealthCareC...econferencewillbeheldattheNewYorkPalaceHotelinNewY...manufacturesandmarketsportablebloodanalysissystems...
Breaking Medicine Technology:U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Syngenta Acquires Innovative Bio Control Technology to Improve Usable Crop Yields 12574 1Syngenta Acquires Innovative Bio Control Technology to Improve Usable Crop Yields 12574 2Syngenta Acquires Innovative Bio Control Technology to Improve Usable Crop Yields 12574 3A WIT Technologies Releases World 26apos 3Bs First Low Cost C Stamp 28TM 29 Based Biotechnology Laboratory in a Box 12572 1A WIT Technologies Releases World 26apos 3Bs First Low Cost C Stamp 28TM 29 Based Biotechnology Laboratory in a Box 12572 2Polycom and AMD Global Telemedicine Inc To Deliver Integrated Visual And Voice Telehealth Capability To Clinicians On The Go 48554 1Polycom and AMD Global Telemedicine Inc To Deliver Integrated Visual And Voice Telehealth Capability To Clinicians On The Go 48554 2Polycom and AMD Global Telemedicine Inc To Deliver Integrated Visual And Voice Telehealth Capability To Clinicians On The Go 48554 3
...tes Recognized as Marker of,Treatment Success -, ...-conducted study being presented at the 59th Annua...y of Liver Diseases (AASLD) shows that,PEGASYS(R) ...in higher,sustained virological response (SVR) rat...s with another pegylated interferon.(1), Comparin...
...,significantly increase the risk of the most commo...ied by researchers at Massachusetts General,Hospit...November 7th issue,of American Journal of Human Ge...s Genome Project" (AGP) established three years ag...genetic risk factors, may lead to more,aggressive ...
Other Medicine Technology:New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 2New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 3New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 4New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 5New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 6New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 7Breakthrough Mapping of Alzheimer's Genome Helps ID Four New Suspect Genes 2Breakthrough Mapping of Alzheimer's Genome Helps ID Four New Suspect Genes 3
(Date:11/27/2009)... KELOWNA,BC,Nov.27/PRNewswire/-UploadableUSBpedome...lness.Acombinationofadvancedaccelerometerfunctiona...rnovertheaccuracyofself-reporteddata.It,snowpossib...nafitnessprogram. ,, CoreHealthTechnologiesison...ogy."Ourhealthchallengesareeasytoadministerandpart...
(Date:11/27/2009)... ROCHESTER,N.Y.,Nov.27/PRNewswire-USNewswire/--Pre...dfortunatelyeveryyear,newvaccinesarebeingaddedtoas...ityforthesameperiodoftime?And,ifnot,whenareadditio... Inthismonth,sissueofPediatrics,theJournaloftheAme...toroftheRochesterGeneralResearchInstitute,basedatR...
(Date:11/27/2009)... and cycling plus low-emission vehicles may reduce... , FRIDAY, Nov. 27 (HealthDay News) -- Encouragin...ng cars would offer much greater public health ben..., U.K. researchers have found. , The study comp...native urban land transport scenarios for London, ...
(Date:11/27/2009)... Multi-purpose bilingual colorin...ed for use by the business community to educate - ...subjects from Safety issues to Dinosuars to ABC,S ... Saint Louis, MO (PRWEB) November 27, 2009 -- ...onics or toys to keep them busy any hour of the da...
(Date:11/26/2009)... PRINCETON,N.J.,Nov.27/PRNewswire/--Thediabetespop...t25yearsandannualmedicalspendingonthediseaseisproj...dingtoastudypublishedintheDecemberissueof Diabetes...CDP),aprogramofNovoNordisk,commissionedtheanalysis...totheforecast,thenumberofAmericanslivingwithdiabet...
Breaking Medicine News(10 mins):Health News:New USB technology adds accountability and convenience to wellness programs 2Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3
...iott Yamin To Perform, LOS ANGELES, Sept. 11 Ope...ty dedicated to helping improve the health and,liv...Lopez, American Idol:,"Idol Gives Back" and Vicky ...ett Family. "E! News" host Giuliana Rancic,emcees ...
...YANG, China, Sept. 11 /Xinhua-PRNewswire-FirstCall...C Bulletin Board: GNPH) ("Genesis" or,the "Company...,s Republic,of China, today announced that the Com...Annual New Drugs Conference (the,"Conference") spo...
... American Podiatric Medical...eventative tips. , Bethes...-09 football season still in its fledgling stages,...ing back for the Ohio State University Buckeyes, c...
...T WORTH, Texas, Sept. 11 Wound Management,Technol... today its,strategic plans for the remainder of th... on bringing the science and technology to the mar...rking,with several major medical groups, physician...
...CLEMSON Black lung disease is not a problem of th...to die from it and associated ailments. , In resp...arded John R. Saylor, associate professor of mecha...lor,s research focuses on a combination of water s...
...rnal of Nutrition Cites Almonds as a Rich Source t...re than 90,percent of the U.S. population does not...n E, according to a special supplement to the,Sept...concluded that vitamin E, among other things, can ...
Other Medicine News:Health News:Operation Smile to Honor Mario Lopez, American Idol: 'Idol Gives Back,' Roma Downey & Mark Burnett Family and Vicky Mense at Smile Gala in Los Angeles 2Health News:Genesis Pharmaceuticals Received New Purchase Orders Worth $12 Million 2Health News:Genesis Pharmaceuticals Received New Purchase Orders Worth $12 Million 3Health News:Foot Injuries Plague Athletes During Fall Sports Season 2Health News:Foot Injuries Plague Athletes During Fall Sports Season 3Health News:Wound Management Technologies, Inc. Announces Strategic Plans for Revenue Growth for Year End and 2009 2Health News:CDC awards Clemson researcher $700,000 to study black lung prevention 2Health News:E-mergency? Majority of U.S. Consumers Lack Essential Vitamin E 2
Eppendorf Research Series 2100 Adjustable-volume Pipette, 20-200 l
...or for sub-microliter pipetting and beyond. Offers...adjustable. Features lPLUS, a direct-drive digital...le ejector buttons to fit large hands or tiny hand...ifferent lengths. Air-displacement mechanism. No r...
...bsystems was designed specifically to combine ergo...features such as the new fast dial system with .01...define this as a new leader in single channel pipe...a custom fit for different hand sizes. The new sho...
...tte is a synonym for pipetting accuracy, a smooth ...operating comfort. Its single, multifunctional but...ow-out as well as eject the tip. Product features...ccuracy and precision. Ejection sleeve can be rem...
Medicine Products: